{"altmetric_id":1812186,"counts":{"readers":{"mendeley":7,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[55373],"posts_count":1},"total":{"posts_count":1}},"citation":{"abstract":"Cancer patients are at high risk for developing sepsis. To our knowledge, there are no studies that evaluated the type of medications utilized and the associated cost in cancer patients with severe sepsis and septic shock.","abstract_source":"pubmed","altmetric_jid":"4f6fa61d3cf058f610007852","authors":["Lama Nazer","Mohammad Al-Shaer","Feras Hawari"],"doi":"10.1007\/s11096-013-9860-2","first_seen_on":"2013-10-08T19:01:48+00:00","issns":["2210-7711","2210-7703"],"journal":"International Journal of Clinical Pharmacy","last_mentioned_on":1381257360,"links":["http:\/\/link.springer.com\/10.1007\/s11096-013-9860-2"],"pdf_url":"http:\/\/link.springer.com\/content\/pdf\/10.1007%2Fs11096-013-9860-2.pdf","pmid":"24104762","pubdate":"2013-10-09T00:00:00+00:00","publisher":"Springer Netherlands","subjects":["pharmacy"],"title":"Drug utilization pattern and cost for the treatment of severe sepsis and septic shock in critically ill cancer patients","type":"article","uri":"http:\/\/link.springer.com\/10.1007\/s11096-013-9860-2","mendeley_url":"http:\/\/www.mendeley.com\/research\/drug-utilization-pattern-cost-treatment-severe-sepsis-septic-shock-critically-ill-cancer-patients"},"altmetric_score":{"score":5.024,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":5.024},"context_for_score":{"all":{"total_number_of_other_articles":3685110,"mean":4.9372923047901,"rank":604661,"this_scored_higher_than_pct":83,"this_scored_higher_than":3076207,"rank_type":"exact","sample_size":3685110,"percentile":83},"similar_age_3m":{"total_number_of_other_articles":95234,"mean":7.6799733915766,"rank":19040,"this_scored_higher_than_pct":79,"this_scored_higher_than":75324,"rank_type":"exact","sample_size":95234,"percentile":79},"this_journal":{"total_number_of_other_articles":240,"mean":2.3283179916318,"rank":28,"this_scored_higher_than_pct":87,"this_scored_higher_than":210,"rank_type":"exact","sample_size":240,"percentile":87},"similar_age_this_journal_3m":{"total_number_of_other_articles":18,"mean":5.2704705882353,"rank":8,"this_scored_higher_than_pct":55,"this_scored_higher_than":10,"rank_type":"exact","sample_size":18,"percentile":55}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":2,"Student  > Ph. D. Student":2,"Professor":1},"by_discipline":{"Medicine and Dentistry":3,"Social Sciences":1,"Pharmacology, Toxicology and Pharmaceutical Science":1}}}},"posts":{"blogs":[{"title":"Drug utilization pattern and cost for the treatment of severe sepsis and septic shock in critically ill cancer patients","url":"http:\/\/sciencealerts.com\/stories\/2524186\/Drug_utilization_pattern_and_cost_for_the_treatment_of_severe_sepsis_and_septic_shock_in_critically_ill_cancer_patients.html","citation_ids":[1812186],"posted_on":"2013-10-08T18:36:00+00:00","summary":"Cancer patients are at high risk for developing sepsis. To our knowledge, there are no studies that evaluated the type of medications utilized and the associated cost in cancer patients with severe sepsis and septic shock.  To describe the drug utilization","author":{"name":"Science Alerts Social Network","url":"http:\/\/sciencealerts.com\/","description":"Science Alerts Social Network"}}]}}